218 related articles for article (PubMed ID: 25247809)
1. Targeting of alpha-v integrins reduces malignancy of bladder carcinoma.
van der Horst G; Bos L; van der Mark M; Cheung H; Heckmann B; Clément-Lacroix P; Lorenzon G; Pelger RC; Bevers RF; van der Pluijm G
PLoS One; 2014; 9(9):e108464. PubMed ID: 25247809
[TBL] [Abstract][Full Text] [Related]
2. Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer.
van den Hoogen C; van der Horst G; Cheung H; Buijs JT; Pelger RC; van der Pluijm G
Am J Pathol; 2011 Nov; 179(5):2559-68. PubMed ID: 21907176
[TBL] [Abstract][Full Text] [Related]
3. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
4. Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.
van der Horst G; van den Hoogen C; Buijs JT; Cheung H; Bloys H; Pelger RC; Lorenzon G; Heckmann B; Feyen J; Pujuguet P; Blanque R; Clément-Lacroix P; van der Pluijm G
Neoplasia; 2011 Jun; 13(6):516-25. PubMed ID: 21677875
[TBL] [Abstract][Full Text] [Related]
5. CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo.
Trikha M; Zhou Z; Nemeth JA; Chen Q; Sharp C; Emmell E; Giles-Komar J; Nakada MT
Int J Cancer; 2004 Jun; 110(3):326-35. PubMed ID: 15095296
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of alphav integrin by retroviral delivery of small interfering RNA reduces multicellular resistance of HT29.
He JM; Wang FC; Qi HB; Li Y; Liang HJ
Cancer Lett; 2009 Nov; 284(2):182-8. PubMed ID: 19435649
[TBL] [Abstract][Full Text] [Related]
7. Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma.
Jagadish N; Fatima R; Sharma A; Devi S; Suri V; Kumar V; Suri A
Tumour Biol; 2018 May; 40(5):1010428318773652. PubMed ID: 29745297
[TBL] [Abstract][Full Text] [Related]
8. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
[TBL] [Abstract][Full Text] [Related]
9. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
[TBL] [Abstract][Full Text] [Related]
10. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
Ciardiello C; Leone A; Lanuti P; Roca MS; Moccia T; Minciacchi VR; Minopoli M; Gigantino V; De Cecio R; Rippa M; Petti L; Capone F; Vitagliano C; Milone MR; Pucci B; Lombardi R; Iannelli F; Di Gennaro E; Bruzzese F; Marchisio M; Carriero MV; Di Vizio D; Budillon A
J Exp Clin Cancer Res; 2019 Jul; 38(1):317. PubMed ID: 31319863
[TBL] [Abstract][Full Text] [Related]
11. 1-Methyl-D-tryptophan potentiates TGF-β-induced epithelial-mesenchymal transition in T24 human bladder cancer cells.
Brito RB; Malta CS; Souza DM; Matheus LH; Matos YS; Silva CS; Ferreira JM; Nunes VS; França CM; Dellê H
PLoS One; 2015; 10(8):e0134858. PubMed ID: 26267811
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of tumor initiation and expression of KCNMA1, MORF4L2 and ASPM genes in the adenocarcinoma of lung xenograft after vorinostat treatment.
Kuo WY; Wu CY; Hwu L; Lee JS; Tsai CH; Lin KP; Wang HE; Chou TY; Tsai CM; Gelovani J; Liu RS
Oncotarget; 2015 Apr; 6(11):8663-75. PubMed ID: 25796627
[TBL] [Abstract][Full Text] [Related]
13. α6β1- and αV-integrins are required for long-term self-renewal of murine embryonic stem cells in the absence of LIF.
Cattavarayane S; Palovuori R; Tanjore Ramanathan J; Manninen A
BMC Cell Biol; 2015 Feb; 16():3. PubMed ID: 25886986
[TBL] [Abstract][Full Text] [Related]
14. In vivo therapy of malignant melanoma by means of antagonists of alphav integrins.
Mitjans F; Meyer T; Fittschen C; Goodman S; Jonczyk A; Marshall JF; Reyes G; Piulats J
Int J Cancer; 2000 Sep; 87(5):716-23. PubMed ID: 10925366
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells.
Zhu J; Pan X; Zhang Z; Gao J; Zhang L; Chen J
Cell Signal; 2012 Jun; 24(6):1323-32. PubMed ID: 22570869
[TBL] [Abstract][Full Text] [Related]
16. Variable effects of alpha v suppression on VEGFR-2 expression in endothelial cells of different vascular beds.
Dardik R; Livnat T; Seligsohn U
Thromb Haemost; 2009 Nov; 102(5):975-82. PubMed ID: 19888537
[TBL] [Abstract][Full Text] [Related]
17. The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma.
Hamaidi I; Coquard C; Danilin S; Dormoy V; Béraud C; Rothhut S; Barthelmebs M; Benkirane-Jessel N; Lindner V; Lang H; Massfelder T
Oncogene; 2019 Jan; 38(1):60-72. PubMed ID: 30076415
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
[TBL] [Abstract][Full Text] [Related]
19. Alphav integrins mediate adhesion and migration of breast carcinoma cell lines.
Wong NC; Mueller BM; Barbas CF; Ruminski P; Quaranta V; Lin EC; Smith JW
Clin Exp Metastasis; 1998 Jan; 16(1):50-61. PubMed ID: 9502077
[TBL] [Abstract][Full Text] [Related]
20. Antisense integrin alphaV and beta3 gene therapy suppresses subcutaneously implanted hepatocellular carcinomas.
Li J; Tan H; Dong X; Xu Z; Shi C; Han X; Jiang H; Krissansen GW; Sun X
Dig Liver Dis; 2007 Jun; 39(6):557-65. PubMed ID: 17374519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
